MarketCap
Facebook
X
Telegram
Land |
 Vereinigte Staaten |
IPO-Jahr |
- |
Branche |
Pharmaeinzelhändler |
Börse |
NASDAQ CAPITAL |
Anteile |
14.3 M |
Marktkapitalisierung |
$ 17.4 M |
EBITDA (LTM) |
$ -55.6 M |
P/E (LTM) |
- |
P/S (LTM) |
0.141244 |
EPS (LTM) |
-1.57 |
Andere Aktien der Branche "Pharmaeinzelhändler"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
Vir Biotechnology
VIR
|
$ 11.18 | 4.98 % | $ 1.55 B | Nasdaq Global Select Market,SPB | USA |
 |
Viking Therapeutics
VKTX
|
$ 32.6 | 2.48 % | $ 3.67 B | Nasdaq Capital Market | USA |
 |
Vanda Pharmaceuticals
VNDA
|
$ 4.91 | 0.8 % | $ 289 M | Nasdaq Global Select Market,SPB | USA |
 |
Verrica Pharmaceuticals
VRCA
|
$ 4.8 | 7.51 % | $ 51.1 M | Nasdaq Global Market | USA |
 |
Viridian Therapeutics
VRDN
|
$ 20.59 | 2.98 % | $ 2.1 B | Nasdaq Capital Market | USA |
 |
Vertex Pharmaceuticals Incorporated
VRTX
|
$ 522.81 | 0.07 % | $ 134 B | Nasdaq Global Select Market,SPB | USA |
 |
Verastem
VSTM
|
$ 8.05 | 1.64 % | $ 558 M | Nasdaq Global Market | USA |
 |
VistaGen Therapeutics
VTGN
|
$ 0.31 | 3.29 % | $ 11.8 M | Nasdaq Global Select Market | USA |
 |
vTv Therapeutics
VTVT
|
$ 30.84 | 2.8 % | $ 122 M | Nasdaq Global Select Market | USA |
 |
Voyager Therapeutics
VYGR
|
$ 2.68 | 1.52 % | $ 157 M | Nasdaq Global Select Market | USA |
 |
Wave Life Sciences Ltd.
WVE
|
$ 3.7 | 1.65 % | $ 624 M | Nasdaq Global Select Market |  Singapore |
 |
Xenetic Biosciences
XBIO
|
$ 2.32 | 2.65 % | $ 3.95 M | Nasdaq Capital Market | USA |
 |
XBiotech
XBIT
|
$ 2.19 | 0.46 % | $ 66.8 M | Nasdaq Global Select Market | USA |
 |
Exicure
XCUR
|
$ 1.19 | 4.38 % | $ 7.49 M | Nasdaq Capital Market | USA |
 |
Xenon Pharmaceuticals
XENE
|
$ 37.19 | 0.24 % | $ 2.95 B | Nasdaq Global Select Market |  Canada |
 |
Xeris Pharmaceuticals
XERS
|
$ 9.56 | 1.53 % | $ 1.53 B | Nasdaq Global Select Market | USA |
 |
X4 Pharmaceuticals
XFOR
|
$ 2.9 | 0.17 % | $ 123 M | Nasdaq Capital Market | USA |
 |
Xencor
XNCR
|
$ 24.95 | 0.86 % | $ 1.85 B | Nasdaq Global Select Market,SPB | USA |
 |
22nd Century Group
XXII
|
$ 0.84 | 4.78 % | $ 155 K | NYSE American | USA |
 |
Zai Lab Limited
ZLAB
|
$ 26.34 | 1.58 % | $ 28.9 B | Nasdaq Global Select Market |  China |
 |
Zentalis Pharmaceuticals
ZNTL
|
$ 2.77 | 2.03 % | $ 199 M | Nasdaq Global Market | USA |
 |
Zoetis
ZTS
|
$ 69.83 | 0.07 % | $ 31 B | NYSE,SPB | USA |
 |
ESSA Pharma
EPIX
|
- | - | $ 8.86 M | Nasdaq Capital Market | Canada |
 |
Adverum Biotechnologies
ADVM
|
- | - | $ 86.2 M | Nasdaq Global Market | USA |
 |
Akero Therapeutics
AKRO
|
- | - | $ 3.67 B | Nasdaq Global Select Market,SPB | USA |
 |
Cidara Therapeutics
CDTX
|
- | - | $ 1.41 B | Nasdaq Global Market | USA |
 |
Corner Growth Acquisition Corp.
COOL
|
- | -0.89 % | $ 114 M | Nasdaq Global Select Market | USA |
 |
Dynavax Technologies Corporation
DVAX
|
- | - | $ 2.02 B | Nasdaq Capital Market | USA |
 |
Iterum Therapeutics
ITRM
|
- | - | $ 591 K | Nasdaq Global Select Market |  Irlanda |
 |
Mersana Therapeutics
MRSN
|
- | - | $ 3.56 B | Nasdaq Global Select Market | USA |
 |
Humanigen
HGEN
|
- | -81.12 % | $ 4.28 M | Nasdaq Global Select Market | USA |
 |
Morphic Holding
MORF
|
- | - | $ 2.42 B | Nasdaq Global Market | USA |
 |
Jounce Therapeutics
JNCE
|
- | - | $ 98.4 M | Nasdaq Global Select Market | USA |
 |
Ayala Pharmaceuticals
AYLA
|
- | - | $ 7.46 M | Nasdaq Global Market |  Israel |
 |
Verona Pharma plc
VRNA
|
- | - | $ 69.7 B | Nasdaq Global Select Market |  Britain |
 |
Clovis Oncology
CLVS
|
- | -7.23 % | $ 13 M | Nasdaq Global Select Market | USA |
 |
Allakos
ALLK
|
- | - | $ 28.6 M | Nasdaq Global Select Market,SPB | USA |
 |
Concert Pharmaceuticals
CNCE
|
- | - | $ 401 M | Nasdaq Global Market | USA |
 |
Evelo Biosciences
EVLO
|
- | -14.46 % | $ 27.9 M | Nasdaq Global Select Market | USA |
 |
Freeline Therapeutics Holdings plc
FRLN
|
- | - | $ 384 M | Nasdaq Global Select Market | Britain |
 |
Genocea Biosciences
GNCA
|
- | -15.0 % | $ 3.04 M | Nasdaq Global Select Market | USA |
|
Amryt Pharma plc
AMYT
|
- | - | $ 621 M | Nasdaq Global Select Market | Britain |
 |
G1 Therapeutics
GTHX
|
- | - | $ 370 M | Nasdaq Global Select Market,SPB | USA |
 |
IGM Biosciences
IGMS
|
- | - | $ 76.9 M | Nasdaq Global Select Market,SPB | USA |
 |
IMV
IMV
|
- | - | $ 13.1 M | Nasdaq Global Select Market | Canada |
 |
Kinnate Biopharma
KNTE
|
- | - | $ 123 M | Nasdaq Global Select Market | USA |
 |
Checkmate Pharmaceuticals
CMPI
|
- | - | $ 231 M | Nasdaq Global Market | USA |
 |
Karuna Therapeutics
KRTX
|
- | - | $ 12.2 B | Nasdaq Global Market,SPB | USA |
 |
Chimerix
CMRX
|
- | - | $ 756 M | Nasdaq Global Select Market | USA |
 |
LogicBio Therapeutics
LOGC
|
- | - | $ 229 M | Nasdaq Global Market | USA |